Advertisement
Screener

NewcelX Ltd. (NCEL) Form 6-K: Report of foreign private issuer, 2023

1.9 / 5 stars · 8/21 Roast Me

Add as a preferred source on Google

NewcelX Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-29: Form 6-K; Period of report 2023-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190759-6k_nlspharma.htm.
  • 2023-12-22: Form 6-K; Period of report 2023-12-22; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190607-6k_nlspharma.htm.
  • 2023-12-06: Form 6-K; Period of report 2023-06-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea189432-6k_nlspharma.htm.
  • 2023-12-04: Form 6-K; Period of report 2023-12-04; Description CURRENT REPORT; Document ea189474-6k_nls.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-296-K2023-12-29REPORT OF FOREIGN PRIVATE ISSUERea190759-6k_nlspharma.htm
2023-12-226-K2023-12-22REPORT OF FOREIGN PRIVATE ISSUERea190607-6k_nlspharma.htm
2023-12-066-K2023-06-30REPORT OF FOREIGN PRIVATE ISSUERea189432-6k_nlspharma.htm
2023-12-046-K2023-12-04CURRENT REPORTea189474-6k_nls.htm
2023-12-046-K2023-12-04REPORT OF FOREIGN PRIVATE ISSUERea189393-6k_nlspharma.htm
2023-12-016-K2023-12-01REPORT OF FOREIGN PRIVATE ISSUERea189322-6k_nlspharma.htm
2023-11-166-K2023-11-16REPORT OF FOREIGN PRIVATE ISSUERea188582-6k_nlspharma.htm
2023-10-256-K2023-10-25REPORT OF FOREIGN PRIVATE ISSUERea187266-6k_nlspharma.htm
2023-10-256-K2023-10-25REPORT OF FOREIGN PRIVATE ISSUERea187173-6k_nlspharma.htm
2023-09-136-K2023-09-13REPORT OF FOREIGN PRIVATE ISSUERea185167-6k_nlspharma.htm
2023-08-306-K2023-08-29REPORT OF FOREIGN PRIVATE ISSUERea184282-6k_nlspharma.htm
2023-07-206-K2023-07-20REPORT OF FOREIGN PRIVATE ISSUERea181522-6k_nlspharma.htm
2023-07-036-K2023-07-03REPORT OF FOREIGN PRIVATE ISSUERea181301-6k_nlspharma.htm
2023-06-146-K2023-06-14REPORT OF FOREIGN PRIVATE ISSUERea180350-6k_nlspharma.htm
2023-06-096-K2023-06-09REPORT OF FOREIGN PRIVATE ISSUERea180037-6k_nlspharma.htm
2023-05-246-K2023-05-24REPORT OF FOREIGN PRIVATE ISSUERea179193-6k_nlspharma.htm
2023-05-086-K2023-05-08REPORT OF FOREIGN PRIVATE ISSUERea178115-6k_nlspharma.htm
2023-05-056-K2023-05-05REPORT OF FOREIGN PRIVATE ISSUERea178079-6k_nlspharma.htm
2023-05-026-K2023-05-02REPORT OF FOREIGN PRIVATE ISSUERea177832-6k_nlspharma.htm
2023-03-276-K2023-03-27REPORT OF FOREIGN PRIVATE ISSUERea175801-6k_nlspharma.htm
2023-02-216-K2023-02-21REPORT OF FOREIGN PRIVATE ISSUERea173983-6k_nlspharma.htm
2023-02-016-K2023-02-01FORM 6-Kea172551-6k_nlspharma.htm
2023-01-256-K2023-01-25REPORT OF FOREIGN PRIVATE ISSUERea172161-6k_nlspharma.htm
2023-01-236-K2023-01-23REPORT OF FOREIGN PRIVATE ISSUERea171991-6k_nlspharma.htm
2023-01-236-K2023-01-23REPORT OF FOREIGN PRIVATE ISSUERea172042-6k_nlspharma.htm
2023-01-126-K2023-01-12REPORT OF FOREIGN PRIVATE ISSUERea171572-6k_nlspharma.htm
2023-01-106-K2023-01-106-Kea171446-6k_nlspharm.htm
Advertisement